Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Chemo is the equivalent of overpaying to be beaten for your own good with no assurance you will ever heal.
DCVax-L is a more proven biologic than it was 4 months - 15 yrs ago Everyday gets closer to patient and stockholder reward, but it sure gets frustrating seeing such a monumental biologic gbm therapy company stock treated so poorly across the board .
Shorts and traders act as heat sinks to quickly dissipate any perceived heat in nwbo or news.
8 tracks were great and gave many of us entertainment for years. I had one and of course I had an FM converter for my AM car radio before that.
Criminality may be discovered and a prosecutor or AG could easily prefer charges of initiate proceedings.
Down to $.70 from $1.15 in Nov for absolutely no reason. Essentially, a new SOC for gbm selling for change instead of $10+ where it should be at a minimum. To make matters worse, no partner due to incompetence in the big pharma businesses.
So far, no comments from anyone with a clue about anything
In 2014 UK designated DCVax-L as first drug to be considered for early access approval under recently enacted EAMS program at that time .
It would make sense the real world information they had gathered would surpass any info available to any other RA in the world and thereby allowing a faster assessment for approval now.
Advent is nothing more than hired help and they do as directed by NWBO
In 2014 UK designated DCVax-L as first drug to be considered for early access approval under recently enacted EAMS program at that time .
It would make sense the real world information they had gathered would surpass any info available to any other RA in the world and thereby allowing a faster assessment for approval now.
The deal will give Gilead access to Immunomedics’ breast cancer treatment drug Trodelvy, another me to therapy if ever approved.
Excellent job senti
The Dr giving the May 10th mess, was the worst deadpan speaker, albeit an excellent doctor.
Well done and thank you for transcript
Alternatively, the Annual Meeting may be accessed telephonically by dialing (213) 338-8477 or (619) 990-6833 and entering webinar ID: 966 5848 8330 and passcode: 113191.
Becoming a parent changes so many things in life and gives new purpose. Congratulations to the new parents. God bless
Nice article and they did a good job of only mentioning Dr Ashkan but not one mention of DCVax-L , the actual name of the biologic used in achieving results shown in the entire article. #17
UK MHRA will be first to approve if a buyout or partnership is not done. The US FDA is too partnered up with big pharma and money changes hands behind the scene.
Any who sell because their little expectations aren’t met at a meeting , need to recheck their maturity in investing.
They only react to $$$$$$$$$ under the table
True and many shorts are surprised true, but many are long actors here. Much like traitors to a country.
Make that argument to the mgt who have made money even on patient deaths , while I have faithfully rode this up and diwn fir years. Mgt could have easily differed salary in excess of $45,000 per year while waiting for approval. Many small company mgt have done that as a way of surviving. These greedy millionaire mgt people have no shame.
So true HappyLibrarian . Mgt may be getting under the table money to not agree
If any in NWBO mgt are slow rolling the approval, they need to be charged with murder for every gbm patient who has died in the last year.
Any long selling at this point, obviously was not in this with success of DCVax-L in mind. At this point the de-risk is at an all time high, with success much higher than at any point any have owned the stock.
You have own shares not borrowed
Integrity may pretty much exempts anyone working for any of these companies on the list.
Cricket is a great fishing bait
To be a whistleblower would require integrity and desire for truth to come out. That pretty much leaves out anyone connected to one of those companies.
An Excellent securities Attorney
I told others and their financial advisor tells them not to buy OTC stocks no matter the allure
so many people here who have never traded in their lives
There were over 30 trades
Curious, are you measured by what your life was 30 yrs ago?
Yes, I can easily see how someone would reject 100% return on an investment. NOT !
I hope you get nervous at $47 . I would be quite happy
The C19 pay to play with zero clinical and no safety study , tells us all we need to know about FDA
It is about time for a transfer of wealth from his account.
JPMorgan Chase was fined nearly $1 billion by the SEC during the fall of 2020 after the company was caught conducting spoofing activity in the precious metals market. Not only that, but the company also found itself in the crosshairs of the U.S. Department of Justice and the CFTC—all for illegal activity that occurred in 2015 and 2016.
But it’s not just the big players that can be on the receiving end of a smack down by the authorities. During August of 2020, an individual day trader was caught manipulating the markets through spoofing activity—actions that netted the trader roughly $140,000 in profits . The trader was ultimately ordered by the CFTC to pay a fine of more than $200,000.
Sort of like a guy stealing a Rolex, gets arrested without recovering the watch and gets fined $20 with no jail time.